Park Square Financial Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Park Square Financial Group, LLC
- $126 Billion
- Q1 2025
A detailed history of Park Square Financial Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Park Square Financial Group, LLC holds 286 shares of REGN stock, worth $161,018. This represents 0.14% of its overall portfolio holdings.
Number of Shares
286
Previous 78
266.67%
Holding current value
$161,018
Previous $55.6 Million
226.47%
% of portfolio
0.14%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,417Shares Held
85MCall Options Held
1.39MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.3 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.76 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.19 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.7 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.25 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $60.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...